Ip, P P
Boerma, A
Walczak, M
Oosterhuis, K
Haanen, J B
Schumacher, T N
Nijman, H W
Daemen, T
Article History
Received: 25 February 2014
Revised: 21 January 2015
Accepted: 23 February 2015
First Online: 26 March 2015
Competing interests
: T Daemen and HW Nijman are co-founders of ViciniVax, a spin-off company from the University Medical Center Groningen developing therapeutic cancer vaccines. TN Schumacher, JB Haanen and K Oosterhuis are inventors on a patent application covering vaccine formats and are as such entitled to a fraction of possible future royalty income, as per NKI-AVL regulations.